GC Wealth Management RIA’s AbbVie ABBV Stock Holding History

GC Wealth Management RIA’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.34M	Sell	37,102 -2,399	-6%	-$516K	0.54%	37
2026 Q1	$8.59M	Sell	39,501 -3,179	-7%	-$705K	0.36%	41
2025 Q4	$9.75M	Sell	42,680 -18,047	-30%	-$4.11M	0.36%	37
2025 Q3	$14.1M	Buy	60,727 +30,758	+103%	+$6.26M	0.46%	29
2025 Q2	$5.56M	Buy	29,969 +22,327	+292%	+$4.15M	0.45%	40
2025 Q1	$1.6M	Buy	7,642 +397	+5%	+$77.2K	0.29%	78
2024 Q4	$1.29M	Sell	7,245 -79	-1%	-$14.5K	0.23%	91
2024 Q3	$1.45M	Sell	7,324 -567	-7%	-$106K	0.25%	84
2024 Q2	$1.35M	Sell	7,891 -779	-9%	-$129K	0.27%	78
2024 Q1	$1.58M	Sell	8,670 -606	-7%	-$104K	0.32%	64
2023 Q4	$1.44M	Buy	+9,276	New	+$1.35M	0.65%	41

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GC Wealth Management RIA's ABBV Position: Q2 2026 in Review

GC Wealth Management RIA reduced its AbbVie (ABBV) stake by 6.1% in Q2 2026, selling an estimated $516K and leaving 37,102 shares worth $9.34M. The position accounts for 0.54% of the portfolio, ranked #37.

GC Wealth Management RIA first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.1M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

GC Wealth Management RIA held 37,102 shares of AbbVie worth $9.34M as of Q2 2026.
GC Wealth Management RIA sold 2,399 AbbVie shares in Q2 2026, an estimated $516K.
AbbVie made up 0.54% of GC Wealth Management RIA's portfolio in Q2 2026, its #37 holding.
GC Wealth Management RIA first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
GC Wealth Management RIA's AbbVie position peaked at $14.1M in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.